Glipizide

Views 1124

Download the GMI DOC on this Topic

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research

10 Diseases Researched for Glipizide

Name	AC	CK	Focus
Diabetes Mellitus: Type 2	3	50
Coronary Artery Disease	2	40
Diabetes: Cardiovascular Illness	2	40
Mortality: All-Cause	1	20
Weight Gain: Drug-Induced	1	20
Weight Problems: Drug-Induced	1	20
Cancers: All	1	10
Hypoglycemia	1	10
Purpuric Dermatosis	1	3
Drug-Induced Toxicity	1	1

3 Adverse Pharmacological Actions Researched for Glipizide

Name	AC	CK	Focus
Cardiotoxic	2	40
Hypoglycemic	1	10
Phototoxicity	1	1

Research Articles 7
Cumulative Knowledge Score 11
Overall Research Rating GOOD

View the Evidence:
7 Abstracts with Glipizide Research

Filter by Study Type

Sort Abstracts

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

Free Sample of Member-Only Features

Although all 30,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 10000 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Friend membership gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to order a membership

[+]

There is a trend toward an increased overall mortality risk with glyburide versus glimepiride and glipizide versus glimepiride (1.39 [0.99-1.96]) in those with documented coronary artery disease.Jun 01, 2010

Click here to read the entire abstract

Pubmed Data : Diabetes Care. 2010 Jun;33(6):1224-9. Epub 2010 Mar 9. PMID: 20215447

Article Published Date : Jun 01, 2010

Study Type : Meta Analysis

Additional Links

Diseases : Coronary Artery Disease, Diabetes: Cardiovascular Illness, Diabetes Mellitus: Type 2, Mortality: All-Cause

Problem Substances : Glipizide, Glyburide

Adverse Pharmacological Actions : Cardiotoxic

[+]

Initiating treatment of type 2 diabetes with glibenclamide or glipizide is associated with increased risk of coronary artery disease in comparison to gliclazide or glimepiride.Dec 01, 2008

Click here to read the entire abstract

Pubmed Data : Diabetes Res Clin Pract. 2008 Dec;82(3):391-5. Epub 2008 Oct 21. PMID: 18945509

Article Published Date : Dec 01, 2008

Study Type : Meta Analysis

Additional Links

Diseases : Coronary Artery Disease, Diabetes: Cardiovascular Illness, Diabetes Mellitus: Type 2

Additional Keywords : Drug: Metformin

Problem Substances : Glibenclamide, Glipizide

Adverse Pharmacological Actions : Cardiotoxic

[+]

Several drugs are associated with weight change of varying magnitudes. Jan 31, 2015

Click here to read the entire abstract

Pubmed Data : J Clin Endocrinol Metab. 2015 Feb ;100(2):363-70. Epub 2015 Jan 15. PMID: 25590213

Article Published Date : Jan 31, 2015

Study Type : Meta Analysis, Review

Additional Links

Diseases : Weight Gain: Drug-Induced, Weight Problems: Drug-Induced

Additional Keywords : Risk Factors, Weight Loss

Problem Substances : Glipizide, Glyburide, Mirtazapine, Olanzapine, Pioglitazone (trade Name Actos), Quetiapine, Risperidone

[+]

Anti-infectives may increase the risk of severe hypoglycemia in glipizide or glyburide users.Aug 01, 2010

Click here to read the entire abstract

Pubmed Data : Clin Pharmacol Ther. 2010 Aug;88(2):214-22. Epub 2010 Jun 30. PMID: 20592722

Article Published Date : Aug 01, 2010

Study Type : Human Study

Additional Links

Diseases : Hypoglycemia

Additional Keywords : Drug-to-Drug Interactions

Problem Substances : Antibiotics, Cephalexin, Cipro, Clarithromycin, Co-trimoxazole, Fluconazole, Glipizide, Glyburide, Levofloxacin

Adverse Pharmacological Actions : Hypoglycemic

[+]

Patients with type 2 diabetes who use sulfonylureas or insulin have an increased risk for cancer-related mortality. Feb 01, 2006

Click here to read the entire abstract

Pubmed Data : Diabetes Care. 2006 Feb;29(2):254-8. PMID: 16443869

Article Published Date : Feb 01, 2006

Study Type : Human Study

Additional Links

Diseases : Cancers: All, Diabetes Mellitus: Type 2

Additional Keywords : Drug: Metformin

Problem Substances : Glipizide, Glyburide, Insulin , Metformin , Sulfonylureas

[+]

A case of Glipizide-induced pigmented purpuric dermatosis has been reported.Nov 01, 1999

Click here to read the entire abstract

Pubmed Data : J Am Acad Dermatol. 1999 Nov;41(5 Pt 2):827-9. PMID: 10534660

Article Published Date : Nov 01, 1999

Study Type : Human: Case Report

Additional Links

Diseases : Purpuric Dermatosis

Problem Substances : Glipizide

[+]

Glipizide exhibits photoxicity in vitro.Jan 01, 2000

Click here to read the entire abstract

Pubmed Data : In Vitr Mol Toxicol. 2000;13(1):17-24. PMID: 10900404

Article Published Date : Jan 01, 2000

Study Type : In Vitro Study

Additional Links

Diseases : Drug-Induced Toxicity

Problem Substances : Glipizide

Adverse Pharmacological Actions : Phototoxicity

Research Articles 7
Cumulative Knowledge Score 11
Overall Research Rating GOOD

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version